gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots.

A quantitative analytical method was used to measure myelinated axon morphometric parameters (e.g., axon area, ratio of axon area/fiber area, and index of circularity) in rat nervous tissue during intoxication with 2,5-hexanedione (HD). Parameters were assessed in nerve roots (dorsal and ventral) and in ascending (gracile fasciculus and spinocerebellar tract) and descending (corticospinal and rubrospinal tracts) spinal cord white matter tracts (L4-L5) of rats intoxicated with HD at two different daily dose-rates (175 or 400 mg HD/kg/day, gavage). For each dose-rate, tissue was sampled at four neurological endpoints: unaffected, slight, moderate, and severe toxicity, as determined by gait analysis and measurements of grip strength. Results indicate that, regardless of the HD dose-rate, axon atrophy (reduced axon area) was a widespread, abundant effect that developed in concert with neurological deficits. The atrophy response occurred contemporaneously in both ascending and descending spinal tracts, which suggests that loss of caliber developed simultaneously along the proximodistal axon axis. In contrast, swollen axons were a numerically small component and were present in nerve roots and spinal tracts only during subchronic intoxication at the lower HD dose-rate (i.e., 175 mg/kg/day). Intoxication at the higher dose-rate (400 mg/kg/day) produced neurological deficits in the absence of axonal swellings. These observations in conjunction with our previous studies of HD-induced peripheral neuropathy (Toxicol. Appl. Pharmacol. 135 (1995) 58; and Toxicol. Appl. Pharmacol. 165 (2000) 127) indicate that axon atrophy, and not axonal swelling, is a primary neuropathic phenomenon.

[1]  M. Abou‐Donia,et al.  Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy , 1988, Brain Research.

[2]  D. Anthony,et al.  The Spatio‐Temporal Pattern of the Axonopathy Associated with the Neurotoxicity of 3,4‐Dimethyl-2,5‐Hexanedione in the Rat , 1983, Journal of neuropathology and experimental neurology.

[3]  E. Lehning,et al.  The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper. , 1997, Neurotoxicology.

[4]  J. Povlishock,et al.  A mechanistic analysis of nondisruptive axonal injury: a review. , 1997, Journal of neurotrauma.

[5]  S. Ochs,et al.  The origin and nature of beading: A reversible transformation of the shape of nerve fibers , 1997, Progress in Neurobiology.

[6]  G. Perry,et al.  Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Moretto,et al.  Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro , 2005, Archives of Toxicology.

[8]  P. Spencer,et al.  Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. , 1976, Brain : a journal of neurology.

[9]  T B Shea,et al.  Microtubule motors, phosphorylation and axonal transport of neurofilaments , 2000, Journal of neurocytology.

[10]  D. Ap n-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein. , 1987 .

[11]  P. Gambetti,et al.  Hexacarbon axonopathy: the morphological expression of altered cytoskeletal translocation. , 1988 .

[12]  P. Spencer,et al.  Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. , 1977, Journal of neuropathology and experimental neurology.

[13]  T. Yokota,et al.  Electrophysiological study of dorsal column function in streptozocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication , 1993, Journal of the Neurological Sciences.

[14]  S. Das,et al.  Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. , 2002, Neurotoxicology.

[15]  G. Losos,et al.  Comparison of Central and Peripheral Nervous System Lesions Caused by High-Dose Short-Term and Low-Dose Subchronic Acrylamide Treatment in Rats , 1986, Toxicologic pathology.

[16]  E. Lehning,et al.  γ-Diketone Peripheral Neuropathy: II. Neurofilament Subunit Content , 2000 .

[17]  A. DeCaprio,et al.  Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. , 1988, Toxicology and applied pharmacology.

[18]  B. Jortner,et al.  Biochemical and morphologic characterization of acrylamide peripheral neuropathy. , 1998, Toxicology and applied pharmacology.

[19]  R. Mayer,et al.  2,5‐hexanedione‐induced intermediate filament aggregates contain ubiquitin‐protein conjugate immunoreactivity and resemble Rosenthal fibres , 1992, Neuropathology and applied neurobiology.

[20]  H. Kretzschmar,et al.  Giant axonal neuropathy , 1972, Acta Neuropathologica.

[21]  N. Muma,et al.  Neurofilaments are intrinsic determinants of axonal caliber , 1993 .

[22]  A. DeCaprio Molecular mechanisms of diketone neurotoxicity. , 1985, Chemico-biological interactions.

[23]  E. Lehning,et al.  γ-Diketone Peripheral Neuropathy: III. Neurofilament Gene Expression , 2001 .

[24]  C. Wade,et al.  Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. , 1980, Journal of environmental pathology and toxicology.

[25]  C. Balaban,et al.  Acrylamide axonopathy revisited. , 2003, Toxicology and applied pharmacology.

[26]  Y. Yagi Effects of 2,5-hexanedione on rat spinal pyramidal tract. , 1994, Sangyo igaku. Japanese journal of industrial health.

[27]  J. Eichberg,et al.  Hexanedione effects on protein phosphorylation in rat peripheral nerve , 1989, Brain Research.

[28]  E. Lehning,et al.  Nerve terminals as the primary site of acrylamide action: a hypothesis. , 2002, Neurotoxicology.

[29]  E. A. O'neill,et al.  Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. , 1985, Toxicology and applied pharmacology.

[30]  R. Nixon,et al.  Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber , 1994, The Journal of cell biology.

[31]  B. Jortner,et al.  Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. , 2000, Toxicology and applied pharmacology.

[32]  G. Divincenzo,et al.  The enlarging view of hexacarbon neurotoxicity. , 1980, Critical reviews in toxicology.

[33]  R. Anderson,et al.  Electrophysiologic deficits in peripheral nerve as a discriminator of early hexacarbon neurotoxicity. , 1984, Journal of toxicology and environmental health.

[34]  A. DeCaprio,et al.  Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. , 1994, Chemical research in toxicology.

[35]  J. Cavanagh,et al.  Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication , 1983, Journal of neurocytology.

[36]  E. Lehning,et al.  Mechanism of calcium entry during axon injury and degeneration. , 1997, Toxicology and applied pharmacology.

[37]  N. Strominger,et al.  Neurotoxicity and protein binding of 2,5-hexanedione in the hen. , 1983, Toxicology and applied pharmacology.

[38]  R. Nixon,et al.  Multiple phosphorylated variants of the high molecular mass subunit of neurofilaments in axons of retinal cell neurons: characterization and evidence for their differential association with stationary and moving neurofilaments , 1988, The Journal of cell biology.

[39]  G. Divincenzo,et al.  The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. , 1980, Toxicology and applied pharmacology.

[40]  J. L. Gill,et al.  Design and analysis of experiments in the animal and medical sciences , 1980 .

[41]  T. Sakaguchi,et al.  Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail , 1993, Neuroscience Letters.

[42]  P. Spencer,et al.  Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. , 1977, Journal of neuropathology and experimental neurology.

[43]  D. Anthony,et al.  dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. , 1987, Toxicology and applied pharmacology.

[44]  L. Autilio‐Gambetti,et al.  Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport , 1990, Brain Research.

[45]  L. Autilio‐Gambetti,et al.  Experimental Increase of Neurofilament Transport Rate: Decreases in Neurofilament Number and in Axon Diameter , 1989, Journal of neuropathology and experimental neurology.

[46]  D. Anthony,et al.  Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. , 1988, Chemical research in toxicology.

[47]  W. Schlaepfer,et al.  2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. , 1986, Neurochemical pathology.

[48]  D. Anthony,et al.  Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione exposure. , 1993, Cell motility and the cytoskeleton.

[49]  A. DeCaprio,et al.  Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. , 1997, Toxicology and applied pharmacology.

[50]  K. Boekelheide,et al.  The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. , 1983, Toxicology and applied pharmacology.

[51]  K. Haglid,et al.  Quantitative and Qualitative Alterations of Neuronal and Glial Intermediate Filaments in Rat Nervous System After Exposure to 2, 5‐Hexanedione , 1991, Journal of neurochemistry.

[52]  R. Stein,et al.  The relationship between axon diameter, myelin thickness and conduction velocity during atrophy of mammalian peripheral nerves , 1983, Brain Research.

[53]  M. Ehrich,et al.  Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. , 2001, Neurotoxicology.

[54]  D. Couri,et al.  Biophysical and electrophysiological studies of hexanedione neurotoxicity. , 1981, Neurotoxicology.

[55]  J. Griffin,et al.  Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication , 1991, Brain Research.

[56]  T. Fujii,et al.  Neurotoxic effects of 2,5-hexanedione on rapidly growing unmyelinated peripheral nerve axons of a rat fetus: dose-effect relationship. , 1993, Environmental research.

[57]  K. Boekelheide,et al.  Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. , 1982, Toxicology and applied pharmacology.

[58]  John A. Wolf,et al.  High Tolerance and Delayed Elastic Response of Cultured Axons to Dynamic Stretch Injury , 1999, The Journal of Neuroscience.

[59]  A. Ludolph,et al.  Experimental and clinical neurotoxicology , 1980 .

[60]  B. Jortner,et al.  Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. , 1995, Toxicology and applied pharmacology.

[61]  S. Yoshimura,et al.  The same chemicals induce different neurotoxicity when administered in high doses for short term or low doses for long term to rats and dogs. , 1992, Molecular and chemical neuropathology.

[62]  E. Lehning,et al.  2,5‐Hexanedione Alters Elemental Composition and Water Content of Rat Peripheral Nerve Myelinated Axons , 1994, Journal of neurochemistry.

[63]  J. Fraher A quantitative study of anterior root fibres during early myelination. , 1972, Journal of anatomy.

[64]  D. Cleveland,et al.  Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. , 1994, Current opinion in cell biology.

[65]  L. Autilio‐Gambetti,et al.  Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication , 1989, Brain Research.

[66]  D. Anthony,et al.  Pathogenetic studies of hexane and carbon disulfide neurotoxicity. , 1995, Critical reviews in toxicology.

[67]  J. Cavanagh,et al.  THE EARLY EVOLUTION OF NEUROFILAMENTOUS ACCUMULATIONS DUE TO 2,5‐HEXANEDIOL IN THE OPTIC PATHWAYS OF THE RAT , 1982, Neuropathology and applied neurobiology.

[68]  L. Autilio‐Gambetti,et al.  Giant axonal neuropathy: acceleration of neurofilament transport in optic axons. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Irwin,et al.  Cross‐Linking of Neurofilament Proteins of Rat Spinal Cord In Vivo After Administration of 2,5‐Hexanedione , 1986, Journal of neurochemistry.

[70]  J. Arezzo,et al.  gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. , 2000, Toxicology and Applied Pharmacology.